# Quell-FM Transcutaneous Electrical Nerve Stimulator

> Active: United States. Medical device record on deviCERTS, compiled from public registries.

- Canonical page: <https://devicerts.com/devices/quell-fm-qsq>
- Manufacturer: [Neurometrix, Inc.](https://devicerts.com/manufacturers/neurometrix-inc) (United States, FDA De Novo applicant)
- Name in the registry: Quell-FM
- Device class: Class II (US FDA)
- FDA product code: QSQ

## Overview

*AI-generated summary, 2026-09-20. Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data is the record.*

The Quell-FM is a transcutaneous electrical nerve stimulation (TENS) device classified as a Class 2 Neurology device (product code QSQ). It is designed to provide electrical stimulation to help reduce fibromyalgia symptoms in adults with high pain sensitivity, leveraging transcutaneous nerve modulation to alleviate discomfort. The device operates on the principle of delivering low-level electrical impulses through the skin to modulate pain perception. Its regulatory designation aligns with the FDA’s classification for neuromodulation devices intended for chronic pain management.

The Quell-FM is intended for use during sleep and is supplied with compatible NeuroMetrix electrodes. It is cleared under FDA 510(k) (DEN210046) via the Direct pathway, adhering to regulatory standards for Class 2 devices. No explicit sterility or single-use/reusable designation is provided, though its intended use suggests a reusable design with proper electrode maintenance. The device is not labeled for MRI compatibility or other imaging environments. Storage and handling follow standard electrical medical device protocols as outlined in its user manual.

## Registrations and authorizations

- **De Novo** · FDA De Novo · United States · DEN210046 · decision 2022-05-18 · decision DENG · status: Active

## Recalls

No recall on record.

## Identifiers

- De Novo Number: DEN210046 [FDA 510(k)]
- FDA product code: QSQ [FDA 510(k)]

## Classification

- Device class: Class II [FDA 510(k)]
- Regulation: 21 CFR Part 882.5888 [FDA 510(k)]
- Advisory committee: Neurology [FDA 510(k)]
- FDA decision: DENG [FDA 510(k)]

## Source and citation

- Cite as: Quell-FM Transcutaneous Electrical Nerve Stimulator, Neurometrix, Inc. deviCERTS medical device catalogue. https://devicerts.com/devices/quell-fm-qsq (data as of 2026-11-22).
- Data sources: [FDA 510(k)](https://open.fda.gov/apis/device/510k/)
- Registry records last synced: 2026-10-06
- Statuses computed as of: 2026-11-22
- JSON: <https://devicerts.com/devices/quell-fm-qsq.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/devices/quell-fm-qsq
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
